AMD Biotech

AMD Biotech

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $264K

Overview

AMD Biotech is a private, established player in the molecular diagnostics sector, leveraging genetics and genomics to create tests for infectious diseases and genetic conditions. Based in the biotech hub of San Diego, the company has likely progressed beyond the pre-revenue stage given its founding year and description as a developer and manufacturer. Its strategic focus on two high-demand diagnostic areas positions it within growing markets, though specific details on its technology and pipeline are not publicly disclosed without website content.

Infectious DiseasesGenetic Disorders

Technology Platform

Inferred to be a molecular diagnostics platform potentially utilizing PCR, NGS, and/or microarray technologies for detecting pathogens and genetic variants.

Pipeline

1
1 drug in pipeline
DrugIndicationStageWatch
add-on pioglitazone + add-on sulphonylureaType 2 Diabetes MellitusApproved

Funding History

1
Total raised:$264K
Grant$264K

Opportunities

The growing global demand for rapid, accurate molecular diagnostics in both infectious disease surveillance and personalized genetic medicine presents a substantial market opportunity.
Trends toward decentralized and point-of-care testing open avenues for innovative, portable platform development.

Risk Factors

Faces intense competition from large diagnostics firms and agile startups, with constant risk of technological obsolescence.
Regulatory hurdles for test approval and uncertain reimbursement landscapes pose significant challenges to commercialization and profitability.

Competitive Landscape

Operates in the highly competitive molecular diagnostics market, competing against global giants like Roche, Abbott, and Qiagen, as well as numerous specialized startups. Differentiation requires continuous innovation in test accuracy, speed, cost, and ease-of-use.